Plasma pteridine concentrations in patients with chronic renal failure

被引:34
|
作者
Yokoyama, K
Tajima, M
Yoshida, H
Nakayama, M
Tokutome, G
Sakagami, H
Hosoya, T
机构
[1] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Minato Ku, Tokyo 1058471, Japan
[2] Meikai Univ, Sch Dent, Dept Dent Pharmacol, Sakado, Saitama 35002, Japan
关键词
chronic renal failure; dihydrobiopterin; NADH; nitric oxide; superoxide; tetrabiopterin;
D O I
10.1093/ndt/17.6.1032
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Pteridine metabolism is impaired in the uraemic state. This may affect cardiovascular function and contribute to malnutrition. We wished to clarify further the impact of impaired pteridine metabolism. Methods. Using the HPLC method, the plasma concentrations of endogenous pteridines were determined in 64 patients with chronic renal failure (33 on intermittent haemodialysis (HD) treatment vs 31 not yet on renal replacement therapy), and in 18 healthy controls. The patients were classified into three groups on the basis of creatinine clearance (Ccr): group (a), Ccr >60 ml/min; group (b), Ccr=10-60 ml/min; group (c), all patients receiving HD. Results. Total neopterin (NP) and biopterin (BP) levels and the NP/BP ratio (a biomarker for macrophage activity) were significantly higher, whereas tetrahydrobiopterin (BH4)/dihydrobiopterin (BH2) ratio (a biomarker for nitric oxide synthase and phenylalanine hydroxylase activities) was significantly lower in, group (c) (118.9+/-11.7 ng/ml, 18.8+/-1.2 ng/ml, 6.79+/-0.53, and 0.26+/-0.06) than in healthy subjects (5.17+/-0.29 ng/ml, 2.83+/-0.19 ng/ml, 1.92+/-0.13, and 1.15+/-0.11; P<0.01). These significant differences were also observed between control and group (b) (12.4+/-2.20 ng/ml, 4.48+/-0.36 ng/ml, 2.81+/-0.48, and 0.74+/-0.08; P<0.01). In groups (a) and (b), significant negative correlations were found between Ccr and the total NP level (r=-0.663, P<0.01), the total BP level (r=-0.492, P<0.01), the BH2 level (r=-0.677, P<0.01), and the NP/BP ratio (r=0.493, P<0.01). Conversely, significant positive correlations were found-between Ccr and the BH4/BH2, ratio (r=0.602, P<0.01). Conclusion. The reduction of quinoid-type BH2 to BH4 is modified in patients with advanced chronic renal failure, before and after the initiation of regular HD treatment. These metabolic alterations may play a role in the impaired macrophage, endothelial constitutive nitric oxide synthase, or phenylalanine hydroxylase (PH) activities observed in such patients.
引用
收藏
页码:1032 / 1036
页数:5
相关论文
共 50 条
  • [41] ACUTE RENAL FAILURE AFTER PTERIDINE APPLICATION
    BRADE, W
    PROPPING, P
    [J]. KLINISCHE WOCHENSCHRIFT, 1970, 48 (20): : 1209 - &
  • [42] ELEVATED LEVELS OF PLASMA LIPOFUSCINS IN PATIENTS WITH CHRONIC RENAL-FAILURE
    HEGEDUS, ZL
    FRANK, HA
    STEINMAN, TI
    ALTSCHULE, MD
    NAYAK, U
    [J]. ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1988, 96 (05): : 211 - 222
  • [43] GLYCATED PLASMA-PROTEINS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    BORDASFONDREDE, M
    SAUSER, E
    JARDEL, C
    JAUDON, MC
    THERVET, F
    ROTTEMBOURG, J
    DELATTRE, J
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1990, 48 (10) : 717 - 721
  • [44] PLASMA HISTAMINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND NEPHROTIC SYNDROME
    GILL, DS
    FONSECA, VA
    BARRADAS, MA
    BALLIOD, R
    MOORHEAD, JF
    DANDONA, P
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (03) : 243 - 245
  • [45] Influence of diet on plasma magnesium content in patients with chronic renal failure
    Sánchez, C
    Planells, E
    Larrubia, M
    Aranda, P
    de la Cruz, AP
    Asensio, C
    Galindo, P
    Mataix, J
    Llopis, J
    [J]. ADVANCES IN MAGNESIUM RESEARCH: PHYSIOLOGY, PATHOLOGY AND PHARMACOLOGY, 2003, : 127 - 129
  • [46] INCREASED PLASMA HOMOCYSTEINE CONCENTRATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    CHAUVEAU, P
    CHADEFAUX, B
    COUDE, M
    AUPETIT, J
    HANNEDOUCHE, T
    KAMOUN, P
    JUNGERS, P
    [J]. MINERAL AND ELECTROLYTE METABOLISM, 1992, 18 (2-5) : 196 - 198
  • [47] PLASMA HISTAMINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND NEPHROTIC SYNDROME
    FONSECA, VA
    GILL, DS
    BARRADAS, MA
    BALLIOD, R
    MOORHEAD, JF
    DANDONA, P
    [J]. CLINICAL SCIENCE, 1990, 78 (04) : P10 - P10
  • [48] Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure
    Chong, KS
    Gardner, RS
    Morton, JJ
    McDonagh, TA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 177A - 177A
  • [49] Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure
    Chong, KS
    Gardner, RS
    Morton, JJ
    Ashley, EA
    McDonagh, TA
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (04) : 355 - 360
  • [50] Fluoride concentrations of blood plasma, urine and saliva of subjects with compensated chronic renal failure.
    Ribeiro, RA
    Rodrigues, CRM
    Ando, T
    Abensur, H
    [J]. JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 977 - 977